Antihistamines

Washington Poison Center warns parents of continued dangers with the Benadrylâ„¢ Challenge

Retrieved on: 
Monday, November 23, 2020

Diphenhydramine is an antihistamine commonly found in over-the-counter sleep aids, cough and cold medications, and allergy medicationsmost notably the brand name Benadryl.

Key Points: 
  • Diphenhydramine is an antihistamine commonly found in over-the-counter sleep aids, cough and cold medications, and allergy medicationsmost notably the brand name Benadryl.
  • It is typically stored in an unsecured or unlocked cabinet, and bulk quantities are available for purchase.
  • WA Poison Center Cases of intentional self-harm or suicidal intent in adolescents ages 13-17 has increased 5% since 2019, and cases of abuse have increased 34%.
  • For questions or emergencies involving diphenhydramine or other potentially harmful substances, call the Washington Poison Center (1-800-222-1222).

Europe Atopic Dermatitis Market and Competitive Landscape 2020: Pipeline, Epidemiology, Market Valuations, Drug Sales, Market Forecast, Drug Forecasts, and Market Shares 2016-2024 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 28, 2020

The "Europe Atopic Dermatitis Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Atopic Dermatitis Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
  • Europe Atopic Dermatitis Market and Competitive Landscape - 2020, provides comprehensive insights into the Atopic Dermatitis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research analyzes and forecasts the Atopic Dermatitis market size and drug sales.
  • Atopic Dermatitis pipeline: Find out drugs in clinical trials for the treatment of Atopic Dermatitis by development phase 3, phase 2, and phase 1, by pharmacological class and company
    Atopic Dermatitis drugs: Identify key drugs marketed and prescribed for Atopic Dermatitis in the US, including trade name, molecule name, and company
    Atopic Dermatitis market valuations: Find out the market size for Atopic Dermatitis drugs in 2019 by countries.

Alkermes to Host Webcast and Conference Call to Discuss ALKS 3831 Development Program

Retrieved on: 
Thursday, May 3, 2018

Management will present new metabolic findings, discuss ALKS 3831's proposed mechanism of action and provide an overview of the clinical development program.

Key Points: 
  • Management will present new metabolic findings, discuss ALKS 3831's proposed mechanism of action and provide an overview of the clinical development program.
  • Alkermes will host a webcast presentation with accompanying slides on Thursday, May 10, 2018, at 8:30 a.m.
  • ET (1:30 p.m. BST), to discuss ALKS 3831 for the treatment of schizophrenia.
  • The webcast presentation will be archived on the Investors section of the Alkermes website for at least 90 days.